A Study of BXQ-350 in Children and Young Adults With Relapsed Solid Tumors
Clinical trial NCT03967093 · TERMINATED
Trial details
- NCT number
- NCT03967093
- Sponsor
- Bexion Pharmaceuticals, Inc.
- Status
- TERMINATED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2019-04-15
- Primary completion
- 2020-01-03
- Enrollment
- 9
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.